TransCode Therapeutics
RNAZ
RNAZ
8 hedge funds and large institutions have $237K invested in TransCode Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-7
Holders Change %
-46.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$219K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.71K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$63 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15 |
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$724K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$113K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$62.4K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$24.8K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$19.8K |
